For Immediate ReleaseChicago, IL – September 20, 2024 – Today, Zacks Equity Research discusses Talen Energy Corp. TLN, TXNM Energy TXNM and FuelCell Energy FCEL.Industry: Alt-EnergyLink: https://www.zacks.com/commentary/2338547/3-alternative-energy-stocks-to-buy-amid-rising-cost-of-installationPer...
BiomX Inc. PHGE recently announced the presentation of data from its Phase 1b/2a study for BX004 — a fixed multi-phage cocktail. BX004 is used for treating cystic fibrosis (CF) patients with chronic...
Investors in Veritex Holdings, Inc. VBTX need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 18, 2024 $40 Call had some of the highest implied...
The Fed reduced the proposed capital requirement increase for large US banks from 19% to 9%, apparently influenced by intense lobbying from the banking sector.
Investors in Sterling Check Corp.STER need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 15, 2024 $20.00 Put had some of the highest implied volatility...
Investors in Tactile Systems Technology, Inc. TCMD need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 18, 2024 $10.00 Call had some of the highest...
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Amkor Technology AMKR is the world's largest independent provider of semiconductor packaging and test services. The Zacks Consesnsus...
Investors in Juniper Networks, Inc. JNPR need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 18, 2024 $32 Call had some of the highest implied...
Investors in Enhabit, Inc. EHAB need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 18, 2024 $7.50 Call had some of the highest implied volatility...
Roche RHHBY announced positive top-line results from a late-study on influenza drug, Xofluza.The CENTERSTONE study was a global phase III trial investigating the efficacy of single-dose Xofluza, taken...